Related Experiment Video
Updated: May 29, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Epidemiology of culture-negative peritonitis in Iranian patients on continuous ambulatory peritoneal dialysis
Iraj Najafi1, Shahrzad Ossareh, Mostafa Hosseini
1Division of Nephrology, Department of Medicine, Hasheminejad Clinical Research Development Center, Tehran University of Medical Sciences, Tehran, Iran. ossareh_s@hotmail.com
Introduction:
Culture-negative peritonitis is a major challenge in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). This study aimed to evaluate the culture-negative peritonitis in patients from the Iranian CAPD Registry.
Materials And Methods:
Data of 1472 patients from 26 CAPD centers were analysed. Peritonitis was defined as any clinical suspicion together with peritoneal leukocyte count of 100/mL and more.
Results:
The patients had been on PD for a mean of 500 ± 402 days. There were a total of 660 episodes of peritonitis observed among 299 patients (peritonitis rate of 1 episode in 34.1 patient-months). Excluding patients with both negative and positive culture results, there were 391 episodes of peritonitis in 220 patients (174 culture-positive episodes in 97 patients and 217 culture-negative episodes in 123). The 1- to 4-year patient survival rates were 85%, 75%, 69%, and 59% for the patients with culture-positive peritonitis, and 92%, 78%, 73% and 63% for the patients with culture-negative peritonitis, respectively (P = .34). The technique survival rates were 90%, 57%, 42%, and 27% and 95%, 85%, 74%, and 40%, respectively (P = .001). On follow-up, there were higher rates of active PD patients, lower rates of PD dropouts, and higher rates of kidney transplantation in patients with culture-negative peritonitis compared to those with culture-positive peritonitis.
Conclusions:
In our patients, the prevalence of culture-negative peritonitis was high (55.9%). Patient survival with culture-negative peritonitis was comparable to those with culture-positive peritonitis and technique survival was higher among those with culture-negative peritonitis.
Insights
Culture-negative peritonitis is common in continuous ambulatory peritoneal dialysis (CAPD) patients. Outcomes for culture-negative peritonitis are comparable to culture-positive cases, with better technique survival.
Area of Science:
- Nephrology
- Infectious Diseases
- Dialysis
Background:
- Culture-negative peritonitis presents a significant clinical challenge in managing peritonitis among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
- This study investigates the characteristics and outcomes of culture-negative peritonitis within the Iranian CAPD Registry.
Purpose of the Study:
- To evaluate the incidence and clinical outcomes of culture-negative peritonitis in CAPD patients.
- To compare patient and technique survival rates between culture-negative and culture-positive peritonitis.
Main Methods:
- Analysis of data from 1472 patients across 26 CAPD centers.
- Peritonitis diagnosis based on clinical suspicion and peritoneal leukocyte count (≥100/mL).
Main Results:
- Culture-negative peritonitis accounted for 55.9% of peritonitis episodes in the study cohort.
- Patient survival rates were similar between culture-negative and culture-positive peritonitis groups (P = .34).
- Technique survival rates were significantly higher for culture-negative peritonitis (P = .001), with more patients remaining on PD and receiving kidney transplants.
Conclusions:
- Culture-negative peritonitis is highly prevalent in this CAPD population.
- While patient survival is comparable, culture-negative peritonitis is associated with superior technique survival and better long-term dialysis outcomes.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Urine Studies II: Urine Culture and Sensitivity Test
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
